Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients (STOPCAV)

Clinical Trial ID NCT01305395

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01305395

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003 2.46
2 Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 2007 2.43
3 The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 2009 2.20
4 Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 2005 1.59
5 Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995 1.58
6 Allograft vasculopathy versus atherosclerosis. Circ Res 2006 1.50
7 Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 2005 1.42
8 Cardiac allograft vasculopathy: a review. Circulation 1997 1.38
9 Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 2004 1.10
10 Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991 1.02
11 Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J 2009 0.84
12 Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 2003 0.83
13 A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant 2003 0.80
Next 100